| Identification | Back Directory | [Name]
Thalidomide-O-C5-NH2 | [CAS]
2307477-23-0 | [Synonyms]
Thalidomide-O-C5-NH2
Thalidomide-4-O-C5-NH2
4-((5-aminopentyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
1H-Isoindole-1,3(2H)-dione, 4-[(5-aminopentyl)oxy]-2-(2,6-dioxo-3-piperidinyl)- | [Molecular Formula]
C18H21N3O5 | [MOL File]
2307477-23-0.mol | [Molecular Weight]
359.38 |
| Hazard Information | Back Directory | [Uses]
Thalidomide-4-O-C5-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. | [IC 50]
Cereblon | [References]
[1] Sato T, et al. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine.?Front Cell Dev Biol. 2021;9:629326. Published 2021 Mar 11. DOI:10.3389/fcell.2021.629326
[2] Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. DOI:10.7554/eLife.57277 |
|
|